[Interaction between typhic somatic agglutinogen and lysozyme with reduction of agglutinability by antityphic agglutinins].
D000373:Agglutinins; D000891:Anti-Infective Agents, Local; D000998:Antiviral Agents; D003879:Dermatologic Agents; D004171:Diploidy; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology*; D009113:Muramidase / Q000494:pharmacology*; D012485:Salmonella typhi / Q000276:immunology*
D000373:Agglutinins; D000891:Anti-Infective Agents, Local; D000998:Antiviral Agents; D003879:Dermatologic Agents; D007106:Immune Sera; D009113:Muramidase
IMMUNE SERUMS/pharmacology; LYSOZYME/pharmacology; SALMONELLA TYPHOSA/immunology